Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF), a biotechnology company, researching, developing, and delivering psychedelic therapeutics to treat addiction, announced today that Awakn Clinics London has received Care Quality Commission’s formal approval to begin treatments for addiction and mental health. The flagship London clinic is Awakn’s third clinic, adding to the Company’s two operating…